Product News and Recalls

March 2012 Yaz/Beyaz Settlement Update

The Court of Common Pleas in Philadelphia has delayed trial deadlines in the cases over Yaz/Yasmin/Beyaz birth control for another 60 days. This puts the deadlines in Philadelphia on par with the U.S. District Court, which issued an order extending deadlines on Feb. 29.

Judge Sandra Moss announced the latest extension on March 9, 2012, referencing the District Court order, which will allow the parties in the case more time to negotiate.

Lopez McHugh is representing multiple plaintiffs against Bayer Healthcare, manufacturer of the birth control pills Yasmin, Yaz, Beyaz, and Ocella. The plaintiffs’ claim, supported by a number of studies, is that Bayer failed to warn users that the company’s birth control pills cause an increased risk of blood clots.

The Yaz group of drugs contains a compound created by Bayer called drospirenone, a synthetic progestogen that may elevate the levels of potassium in the body. The most common serious injuries from these drugs are blood clots, pulmonary embolisms, strokes, or gallbladder removals.

If you or someone you love developed a blood clot or gallbladder disease while taking Yaz, Yasmin, Beyaz, or Ocella, you may be eligible to recover damages. Please contact Lopez McHugh for a FREE consultation with a qualified and trusted attorney who can answer your questions and ensure your legal rights are protected. Call today because if you wait too long, you may be barred from recovering for your injuries by your state’s time limits.

The following birth control pills contain drospirenone and all have a higher risk of injury: Beyaz, Gianvi, Loryna, Ocella, Safyral, Syeda, Yasmin, Yaz, and Zarah.